The VALIDATE Network aims to accelerate vaccine development for globally significant diseases caused by complex neglected intracellular pathogens. Our initial focus is on TB, leishmaniasis, melioidosis, and leprosy, and we have over 260 members from 42 countries.
Together with the British Society for Immunology (BSI), VALIDATE is hosting a scientific conference on the 2 Oct (afternoon) and 3 Oct (full day) 2019 on ‘Vaccine Development for Neglected Intracellular Pathogens’ at The Wembley Drum, London.
The conference is open to anyone interested in vaccine R&D for our focus pathogens, and will include presentations by keynote speakers and researchers in the field, a poster session with drinks reception, and a conference dinner. The talks will be grouped around three sessions: ‘Tissue-specific immunity, host-pathogen interactions, macrophages, and the microenvironment’, ‘Biomarkers’ (including omics and Big Data), and ‘’Latest vaccine developments’. Keynote speakers are:
• Prof Clare Lloyd (Imperial College London)
• Prof Tracy Hussell (University of Manchester)
• Dr January Weiner (Max Planck Institute for Infection Biology)
• Prof Stephen Gordon (University College Dublin)
• Assoc Prof Paul Brett (University of Nevada, Reno)
• Prof Mark Hatherill (University of Cape Town)
Registration is currently open and places are limited, so register early to avoid disappointment. The call for both talk and poster abstracts closes on 17 July 2019.
To find out more details about the programme and how to register, visit www.validate-network.org/annual-meeting